Advertisement
Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist treatments

Review Compares Outcomes, Safety for Once-Weekly GLP-1RAs

0
Greater reduction of HbA1c, fasting plasma glucose, body weight for dulaglutide, exenatide, taspoglutide
For patients with inflammatory bowel disease treated with anti-tumor necrosis factor therapy

Skin Lesions for 29 Percent With Anti-TNF Treatment in IBD

0
All but 11 percent of patients were managed successfully without needing to stop treatment
A mobile stroke treatment unit is feasible for providing acute stroke treatment

Mobile Stroke Treatment Unit Feasible for Acute Stroke Care

0
Significantly shorter times from door to CT completion and to intravenous thrombolysis
Androgen deprivation therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease

ADT for Prostate CA Tied to Increased Alzheimer’s Risk

0
Research suggests dose-dependent effect
Compared to their international peers

Survey: U.S. PCPs Feel Ill-Prepared for Complex Care

0
For example, fewer than half feel they're prepared to manage dementia patients
The combination of effective transmission of knowledge

Med Ed Can Be Improved for High-Value, Cost-Conscious Care

0
Review shows knowledge transmission, reflective practice, supportive environment aid learning
Fewer American families are struggling to pay medical bills

CDC: Fewer Americans Struggling With Medical Bills

0
U.S. report shows 12 million are no longer in families having trouble paying for health care
The prices of cancer drugs vary greatly across high-income countries

Variation in Prices of Cancer Drugs in High-Income Countries

0
Difference in drug price between highest-, lowest-priced countries varies between 28 and 388 percent
For patients with chronic hepatitis C virus (HCV)

AFP Levels Predict Fibrosis Regression After SVR in Hep C

0
Lower α-fetoprotein, HCV type 2 tied to liver fibrosis regression after sustained virological response
Researchers are zeroing in on factors that may increase the risk of leukemia after breast cancer treatment

Etiology of Leukemia in Breast Cancer Survivors Explored

0
Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy